Characterization of Group B Streptococcus Isolated from Women in Saitama City, Japan
|
|
- Hector Fitzgerald
- 6 years ago
- Views:
Transcription
1 Jpn. J. Infect. Dis., 65, , 2012 Original Article Characterization of Group B Streptococcus Isolated from Women in Saitama City, Japan Hiroyuki Ueno*, Yoshihiko Yamamoto**, Akiko Yamamichi, Koji Kikuchi, Sumie Kobori, and Motonobu Miyazaki Saitama City Institute of Health Science and Research, Saitama , Japan (Received February 22, Accepted August 13, 2012) SUMMARY: Streptococcus agalactiae (group B streptococcus; GBS) is a common cause of neonatal sepsis and meningitis. Intrapartum antibiotic prophylaxis is effective in reducing neonatal GBS disease. Penicillin is recommended for intrapartum antibiotic prophylaxis; however, other antibiotics are administered to pregnant women with penicillin allergy. Serotyping and antibiotic susceptibility testing were performed on 376 GBS isolates collected from vaginal swabs in Saitama City. Of the 376 isolates, 328 (87.2z) were obtained from obstetrics and gynecology clinics. Although approximately 80z of the isolates (299/376) were from women of reproductive age (age, years), no definite information on their pregnancy status was obtained. The most frequent serotype was V (19.1z) followed by Ib (18.6z), III (16.2z), VI (14.9z), and Ia (14.6z). None of the isolates were resistant to penicillins and cephalosporins. Isolates that were resistant to erythromycin (12.8z), clindamycin (9.0z), ofloxacin (19.4z), levofloxacin (18.4z), and tetracycline (46.5z) weredetected.therewasahighprevalenceof resistance to erythromycin (39.3z) and clindamycin (27.9z) in serotype III. In addition, almost all serotype Ib isolates were resistant to ofloxacin and levofloxacin (both, 91.4z). Pulsed-field gel electrophoresis analysis on certain GBS isolates (serotype Ib, III, and V) indicated that there was genetic diversity among the resistant isolates obtained from a limited area of Japan. In conclusion, present intrapartum antibiotic prophylaxis with penicillins would be effective in Japan; however, performing susceptibility testing before administering other antibiotics is important in order to ensure activity against the relevant isolate. INTRODUCTION Streptococcus agalactiae (group B streptococcus; GBS) is one of the leading causes of neonatal sepsis and meningitis. Invasive GBS infection in newborns during the first week of life, known as early-onset GBS disease, is mainly caused by vertical transmission of GBS from colonized mothers to their infants during labor or delivery. Approximately 10z 30z of pregnant women are colonized with GBS, and the incidence of early-onset GBS disease is per 1,000 live births (1 4). Intrapartum antibiotic prophylaxis is effective in reducing early-onset GBS disease (5). In 1996, the Centers for Disease Control and Prevention (CDC) published consensus guidelines (6) for the prevention of neonatal GBS disease; these guidelines were revised in 2002 (7). The revised guidelines recommended the screening of all pregnant women between 35 and 37 weeks of gestation for vaginal and rectal colonization with GBS. Further, the guidelines recommended intrapartum antibiotic prophylaxis for colonized pregnant women. In 2008, the Japan Society of Obstetrics *Corresponding author: Mailing address: Department of Microbiology, Saitama City Institute of Health Science and Research, Suzuya, Chuou-ku, Saitama City , Japan. Tel: , Fax: , wes47-h1u1@city.saitama.lg.jp **Present address: Sendai Medical Center, Sendai , Japan. and Gynecology also presented guidelines (8) for the prevention of neonatal GBS disease. Penicillins are the antibiotics of choice for intrapartum antibiotic prophylaxis. GBS has been considered to be uniformly susceptible to penicillins; however, clinical GBS isolates with reduced penicillin susceptibility have been reported (9). On the other hand, alternative antibiotics are administrated for pregnant women with penicillin allergy, such as clindamycin, erythromycin, cefazolin, or vancomycin. In several countries, both clindamycin and erythromycin resistance has been reported in GBS isolates (10 17). There are 10 GBS serotypes (Ia, Ib, and II to IX) based on variations in the capsular polysaccharide, a major virulence factor that helps the microorganism to evade the host's defense mechanisms. The GBS serotype IX was recently identified (18); hence, little epidemiological data are available for serotype IX at present. GBS vaccines based on capsular polysaccharide expression have been investigated as a tool for reducing maternal colonization and preventing transmission to neonates (19,20). Although the predominant serotypes obtained from colonized pregnant women are different in each country (21), the serotypes commonly causing neonatal GBS disease are Ia, III, and V (10,12,14). Other studies (10 12,22) have also identified serotype V that is associated with erythromycin resistance. In this study, we reported the phenotypic characteristics of GBS isolates collected from vaginal swabs by serotyping and antibiotic susceptibility testing. In addition, we performed pulsed-field gel electrophoresis 516
2 (PFGE) in order to determine the clonal relationship of the GBS isolates. MATERIALS AND METHODS GBS isolates: From April 2007 to March 2010, 376 GBS isolates were collected from vaginal swabs of women who visited 11 clinics in Saitama City. Of the 376 isolates, 328 (87.2z) were obtained from obstetrics and gynecology clinics. Although almost 80z of the isolates (299/376) were from women of reproductive age (age, years), no definite information on their pregnancy status was obtained. Each isolate was confirmed as GBS based on the colony characteristics and determination of the Lancefield group by a latex agglutination grouping kit (Prolex Streptococcal Grouping Latex Kit; Iwaki Co., Tokyo, Japan). Serotyping and molecular capsule typing: Serotyping was performed by slide agglutination tests with rabbit antisera (Group B Streptococci Typing Sera; Denka Seiken,Tokyo,Japan)toserotypesIa,Ib,II,III,IV,V, VI, VII, and VIII. Multiplex serotyping PCR assay (Ia, Ib, and II to VIII) (23) was carried out for GBS isolates that were not typeable by the slide agglutination tests. In addition, serotype IX-specific PCR (24) was performed following the multiplex PCR. Antibiotic susceptibility testing: We determined the minimal inhibitory concentrations (MICs) by the broth microdilution method (Dry Plate `EIKEN'; Eiken Kagaku Co., Tokyo, Japan) following the Clinical and Laboratory Standards Institute (CLSI) guidelines (25). We confirmed the accuracy by using the quality control strain, Streptococcus pneumoniae ATCC 49619, which was recommended by the CLSI. GBS isolates were tested for susceptibility to benzylpenicillin, ampicillin, erythromycin, clindamycin, cefazolin, cefotaxime, ceftriaxone, cefepime, meropenem, vancomycin, linezolid, ofloxacin, levofloxacin, and tetracycline. PFGE: PFGE analysis was performed on GBS isolates serotyped as Ib, III, and V. GBS cells in agarose plugs were lysed with mutanolysin (50 U) for 24 h at 379C, and chromosomal DNA was digested with the restriction enzyme SmaI (80U)for16hat309C. Electrophoresis was performed as described previously (26) by using the CHEF-DRII system (Bio-Rad, Hercules, Calif., USA). The PFGE banding patterns were analyzed with Fingerprinting II Software (Bio-Rad). Dice's coefficient was used to determine the similarity between each banding pattern, and a dendrogram was constructed by using the unweighted-pair group method with arithmetic averages with a tolerance coefficient of 0.72z. RESULTS Of the 376 isolates, 323 were serotyped by slide agglutination tests. Multiplex PCR assay could determine capsular type for 50 of the 53 isolates, which were not typeable by slide agglutination tests. Of the remaining 3 isolates, 1 isolate was typed by the serotype IX-specific PCR. Finally, based on the serotyping and molecular capsule typing, 374 isolates were determined to be from 10 serotypes in this study (Fig. 1). The most frequent serotype was V (19.1z) followed Fig. 1. Serotype distribution of 376 GBS isolates from vaginal swabs. Number of serotypes determined by PCR: Ia (8), Ib (12), II (1), III (4), IV (1), V (12), VI (2), VII (1), VIII (9), IX (1). NT, not typeable. by Ib (18.6z), III (16.2z), VI (14.9z), and Ia (14.6z). Serotypes IV (0.5z), VII (0.8z), and IX (0.3z) were less common. MICs of the antibiotics were determined in all 376 GBS isolates (Table 1). None of the isolates were resistant to penicillins such as benzylpenicillin and ampicillin. MIC of benzylpenicillin was Ã0.06 mg/ml in all isolates. Furthermore, all isolates were susceptible to cefotaxime, ceftriaxone, cefepime, meropenem, vancomycin, and linezolid. Although the CLSI guidelines do not specify susceptibility breakpoints for cefazolin, MIC of cefazolin were Ã0.25 mg/ml in all isolates. Isolates resistant to erythromycin, clindamycin, ofloxacin, levofloxacin, and tetracycline were found. In total, 48 isolates (12.8z) were resistant to erythromycin, including 24 isolates (6.4z) with high MIC (À32 mg/ml); 34 isolates (9.0z) were resistant to clindamycin, including 28 isolates (7.4z) with high MIC (Æ32 mg/ml). With respect to fluoroquinolones, 73 (19.4z) and 69 (18.4z) isolates were resistant to ofloxacin and levofloxacin, respectively. All of the 69 isolates with high MIC (À32 mg/ml) to ofloxacin were also highly resistant to levofloxacin (À32 mg/ml). Regarding ofloxacin, 101 isolates (26.9z) showed intermediate susceptibility, remarkably more than that to levofloxacin (0.8z). Further, 175 GBS isolates (46.5z), i.e., nearly half of the tested isolates, were resistant to tetracycline. Table2showsthenumberofisolatesresistanttoantibiotics by the serotype. There was a high prevalence of isolates that were resistant to erythromycin (39.3z) and clindamycin (27.9z) inserotypeiii.almostallofthe serotype Ib isolates were resistant to ofloxacin and levofloxacin (both, 91.4z). In both serotype VI and VIII, few isolates were resistant to these antibiotics. Serotype Ib, III, and V showed higher prevalence of isolates that were resistant to erythromycin, clindamycin, ofloxacin, or levofloxacin than the other serotypes. Therefore, PFGE analysis was performed on 55 isolates including 18 isolates from serotype Ib, 23 isolates from serotype III, and 14 isolates from serotype V. These
3 Antibiotic Table1. MICsofthe376GBSisolatesto14antibiotics MIC (mg/ml) Ã À32 No. of resistance isolates (z) Benzylpenicillin 376 Ampicillin Erythromycin i 8 r 3 r 9 r 4 r 24 r 48 (12.8) Clindamycin i 1 r 1 r 2 r 2 r 28 r 34 (9.0) Cefazolin 1) Cefotaxime Ceftriaxone Cefepime Meropenem Vancomycin Linezolid Ofloxacin i 4 r 69 r 73 (19.4) Levofloxacin i 24 r 45 r 69 (18.4) Tetracycline i 5 r 26 r 63 r 81 r 175 (46.5) 1) : The Clinical and Laboratory Standards Institute guidelines do not specify susceptibility breakpoints for cefazolin. i, intermediate susceptibility; r,resistant. Table 2. Distribution of isolates resistant to each antibiotic by the serotype Serotype (No. of isolates) No. of isolates resistant (z) toeachantibiotic Erythromycin Clindamycin Tetracycline Ofloxacin Levofloxacin Ia (55) 5 (9.1) 43 (78.2) 1 (1.8) Ib (70) 5 (7.1) 5 (7.1) 5 (7.1) 64 (91.4) 64 (91.4) II (15) 2 (13.3) 1 (6.7) 13 (86.7) III (61) 24 (39.3) 17 (27.9) 53 (86.9) 4 (6.6) 4 (6.6) IV (2) 1 (50) V (72) 11 (15.3) 10 (13.9) 56 (77.8) 2 (2.8) 1 (1.4) VI (56) 1 (1.8) 1 (1.8) VII (3) VIII (39) 1 (2.6) 1 (2.6) 1 (2.6) IX (1) 1 (100) 1 (100) NT (2) 1 (50) Total (376) 48 (12.8) 34 (9.0) 175 (46.5) 73 (19.4) 69 (18.4) isolates consisted mainly of resistant isolates. We successfully obtained the PFGE banding patterns for all 55 isolates. Dendrogram of the PFGE banding patterns is shown in Fig. 2. PFGE banding patterns were roughly divided into 4 groups by serotype, and identical banding patterns were found in some isolates. In isolates with a different serotype, the banding patterns were not similar (Æ70z dendrogram similarity). With respect to the relationship between banding pattern and susceptibility, almost all isolates with similar banding patterns showed the same susceptibility to erythromycin, clindamycin, and tetracycline. In contrast, some isolates with identical banding patterns showed different susceptibility to fluoroquinolones. DISCUSSION Epidemiological study of GBS serotypes is important because the GBS serotype is associated with pathogenicity (10,12,14) and antibiotic susceptibility (10 12,22). In addition, the development and formulation of current multivalent GBS vaccines depends on accurate population data of the serotype distribution (20). In this study, to determine the serotype of GBS isolates, we used a two-step identification scheme. First, we applied the serotype-specific slide agglutination test, which determined the serotypes of 85.9z isolates. The percentage of non-typeable isolates (14.1z) wasrelatively higher than that reported elsewhere (21). As for these untyped isolates, 51 of 53 isolates were identified successfully by PCR-based molecular capsule typing method. Although we did not evaluate the PCR-based method, PCR-based capsular typing is an essential tool for analyzing the seroprevalence and serotypic shift of GBS from pregnant women. Additionally, the new serotype, IX, was easily identified using the molecular method. The GBS serotype IX was isolated in this study, but it was still rare in Japan (1/376 GBS). Even with the combination of serotyping and molecular capsule typing, 2 out of the 376 isolates remained untyped. For precise analysis, the region involved in capsular synthesis should be genetically determined. Previous studies (27 30) in Japan showed that sero- 518
4 Fig. 2. The dendrogram and antibiotic susceptibility of the 55 GBS isolates. EM, erythromycin; CLDM, clindamycin; TC, tetracycline; OFLX, ofloxacin; LVFX, levofloxacin S, susceptible; I, intermediate susceptibility; R, resistant. typesvi(24z 27z) and VIII (19z 36z) are most frequently isolated from vaginal cultures of pregnant women ( ). Global GBS serotype distribution as revealed by a meta-analysis indicated that the seroprevalence in Japan (VI and VIII predominant) is unique. In this study, the prevalence of serotypes VI and VIII was 14.9z and 10.4z, respectively, indicating lower prevalence than that shown in previous reports. Another difference was the prevalence of serotype V, whichwasreportedtobe3z 9z by previous reports on Japanese GBS. However, this study showed that serotype V was the most frequently observed serotype (16.0z by slide agglutination test, 19.1z by a combination of serotyping and molecular capsule typing). Although all of our isolates were from vaginal specimens, and approximately 80z of the isolates were from women of reproductive age, our data set lacked information on the pregnancy status. Thus, it is possible that 519
5 the pregnancy status might affect the seroprevalence. Additionally, temporal and/or geographical difference might influence the prevalence. In Japan, clinical GBS isolates with reduced penicillin susceptibility have been reported (9). However, all tested isolates in this study were susceptible to penicillins, indicating that they would be effective as the first-line agents on intrapartum antibiotic prophylaxis. Conversely, some women with penicillin allergy require other antibiotics such as clindamycin, erythromycin, cefazolin, or vancomycin, which are recommended in the guidelines (7,8). All isolates in this study were susceptible to cefazolin and vancomycin. However, 12.8z and 9.0z of the tested isolates were resistant to erythromycin and clindamycin, respectively. These results are higher than that of previous studies (3z and 1z) in Japan (28). Susceptibility testing should be recommended before administering erythromycin or clindamycin in order to ensure activity against the isolate. In the USA, the rates of resistance are relatively high (10,11). Consequently, the revised CDC guidelines in 2010 (31) excluded erythromycin from the recommended alternative antibiotics. The majority of erythromycin- and clindamycinresistant GBS were from serotype III, one of the most frequent serotype causing neonatal GBS disease (10,12,14,32). This result differs from previous studies (10 12,22) that identified serotype V to be associated with erythromycin resistance. Most of the fluoroquinolone-resistant isolates from vaginal swabs were serotype Ib, which was in agreement with previous studies on invasive GBS isolates (33). Although small variations in the PFGE profile were observed in the serotype Ib isolates, some isolates with identical banding patterns showed different susceptibility to fluoroquinolones. Previous reports (34 37) indicated that the majority of quinolone resistance in GBS was caused by point mutations in the quinolone resistance-determining regions (QRDRs). It is believed that the PFGE banding patterns are not affected by point mutations, because these mutations in QRDRs would affect neither the whole genome size nor digestion with restriction enzyme. Conversely, regarding erythromycin, clindamycin, and tetracycline, isolates with the same resistance patterns in a serotype did not always show similar banding patterns. This observation indicates that the resistant isolates did not originate from a single clone and that there was genetic diversity among resistant isolates obtained from a limited area of Japan. There are some cases of neonates being born with early-onset GBS disease to women who received appropriate intrapartum antibiotic prophylaxis (4). This suggests that appropriate intrapartum antibiotic prophylaxis will not eliminate all cases of early-onset GBS disease. Although no licensed vaccine is available currently, immunization with a GBS vaccine has the potential to overcome these problems, including antibiotic resistance. There is a possibility that some of the GBS isolates in this study were from non-pregnant women. Thus, we should be aware of this when using the data. However, these results can be useful as a basis of information on GBS. Acknowledgments We thank members of Urawa Medical Association-Medical Center for their help in collecting GBS isolates. Conflict of interest None to declare. REFERENCES 1. Trijbels-Smeulders, M.A., Kolláee, L.A., Adriaanse, A.H., et al. (2004): Neonatal group B streptococcal infection: incidence and strategies for prevention in Europe. Pediatr. Infect. Dis. J., 23, Luck, S., Torny, M., d'agapeyeff, K., et al. (2003): Estimated early-onset group B streptococcal neonatal disease. Lancet, 361, Sensini,A.,Tissi,L.,Verducci,N.,etal.(1997):Carriageof group B Streptococcus in pregnant women and newborns: a 2- year study at Perugia General Hospital. Clin. Microbiol. Infect., 3, Goins, W.P., Talbot, T.R., Schaffner, W., et al. (2010): Adherence to perinatal group B streptococcal prevention guidelines. Obstet. Gynecol., 115, Boyer, K.M. and Gotoff, S.P. (1986): Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N. Engl. J. Med., 314, Centers for Disease Control and Prevention (1996): Prevention of perinatal group B streptococcal disease: a public health perspective. Morbid. Motal.Wkly. Rep., 45 (RR-07), Schrag, S., Gorwitz, R., Fultz-Butts, K., et al. (2002): Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. Morbid. Mortal. Wkly. Rep., 51 (RR-11), Japan Society of Obstetrics and Gynecology, Japan Association of Obstetricians and Gynecologists (2008): ``Sanfujinka shinryo guideline sankahen 2008.'' p Japan Society of Obstetrics and Gynecology, Tokyo (in Japanese). 9. Kimura, K., Suzuki, S., Wachino, J., et al. (2008): First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob. Agents Chemother., 52, Phares, C.R., Lynfield, R., Farley, M.M., et al. (2008): Epidemiology of invasive group B streptococcal disease in the United States, JAMA, 299, Castor, M.L., Whitney, C.G., Como-Sabetti, K., et al. (2008): Antibiotic resistance patterns in invasive group B streptococcal isolates. Infect. Dis. Obstet. Gynecol., Andrews, J.I., Diekema, D.J., Hunter, S.K., et al. (2000): Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere. Am. J. Obstet. Gynecol., 183, de Azavedo, J.C., McGavin, M., Duncan, C., et al. (2001): Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob. Agents Chemother., 45, Weisner, A.M., Johnson, A.P., Lamagni, T.L., et al. (2004): Characterization of group B streptococci recovered from infants with invasive disease in England and Wales. Clin. Infect. Dis., 38, Savoia, D., Gottimer, C., Crocilla', C., et al. (2008): Streptococcus agalactiae in pregnant women: phenotypic and genotypic characters. J. Infect., 56, Darbar, A.A. and Gilbert, G.L. (2007): Phenotypical and genotypical characteristics of invasive group B Streptococcus isolates in Western Sydney Pathology, 39, Zeng, X., Kong, F., Wang, H., et al. (2006): Simultaneous detection of nine antibiotic resistance-related genes in Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization assay. Antimicrob. Agents Chemother., 50, Slotved, H.C., Kong, F., Lambertsen, L., et al. (2007): Serotype IX, a proposed new Streptococcus agalactiae serotype.j.clin. Microbiol., 45, Baker, C.J. and Edwards, M.S. (2003): Group B streptococcal conjugate vaccines. Arch. Dis. Child., 88, Johri, A.K., Paoletti, L.C., Glaser, P., et al. (2006): Group B Streptococcus: global incidence and vaccine development. Nat. Rev. Microbiol., 4, Ippolito, D.L., James, W.A., Tinnemore, D., et al. (2010): Group B Streptococcus serotype prevalence in reproductive-age 520
6 women at a tertiary care military medical center relative to global serotype distribution. BMC Infect. Dis., 10, Gherardi, G., Imperi, M., Baldassarri, L., et al. (2007): Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy. J. Clin. Microbiol., 45, Poyart, C., Tazi, A., Ráeglier-Poupet, H., et al. (2007): Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci. J. Clin. Microbiol., 45, Kong, F., Lambertsen, L.M., Slotved, H.C., et al. (2008): Use of phenotypic and molecular serotype identification methods to characterize previously nonserotypeable group B streptococci. J. Clin. Microbiol., 46, Clinical and Laboratory Standards Institute (2011): Performance Standards for Antimicrobial Susceptibility Testing; 21st Informational Supplement. M100-S21. p Clinical and Laboratory Standards Institute, Wayne, Pa. 26. Wakimoto, H., Ogura, M., Yano, H., et al. (2008): Pulsed field gel electrophoresis analysis conditions for molecular epidemiological Group B Streptococcus identification. J. Jpn. Assoc. Infect. Dis., 82, Lachenauer, C.S., Kasper, D.L., Shimada, J., et al. (1999): Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J. Infect. Dis., 179, Matsubara, K., Nishiyama, Y., Katayama, K., et al. (2001): Change of antimicrobial susceptibility of group B streptococci over 15 years in Japan. J. Antimicrob. Chemother., 48, Terakubo, S., Ichiman, Y., Takemura, H., et al. (2003): Serotypes and antibody levels of group B streptococci in pregnant women. J. Jpn. Assoc. Infect. Dis., 77, (in Japanese). 30. Wakimoto, H., Wakimoto, Y., Yano, H., et al. (2011): Antimicrobial susceptibility and serotype distribution in perinatal group B streptococcus isolates a multicenter study. J. Jpn. Assoc. Infect. Dis., 85, (in Japanese). 31. Verani, J.R., McGee, L. and Schrag, S.J. (2010): Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC, Morbid. Mortal. Wkly. Rep., 59 (RR-10), Hoshina, K., Suzuki, Y., Nishida, H., et al. (2002): Trend of neonatal group B streptococcal infection during the last 15 years. Pediatr. Int., 44, Murayama, S.Y., Seki, C., Sakata, H., et al. (2009): Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections. Antimicrob. Agents Chemother., 53, Kawamura, Y., Fujiwara, H., Mishima, N., et al. (2003): First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyra and parc. Antimicrob. Agents Chemother., 47, Wehbeh, W., Rojas-Diaz, R., Li, X., et al. (2005): Fluoroquinolone-resistant Streptococcus agalactiae: epidemiology and mechanism of resistance. Antimicrob. Agents Chemother., 49, Tazi, A., Gueudet, T., Varon, E., et al. (2008): Fluoroquinoloneresistant group B streptococci in acute exacerbation of chronic bronchitis. Emerg. Infect. Dis., 14, Wu, H.M., Janapatla, R.P., Ho, Y.R., et al. (2008): Emergence of fluoroquinolone resistance in group B streptococcal isolates in Taiwan. Antimicrob. Agents Chemother., 52,
ANTIMICROBIAL SUSCEPTIBILITY DETECTION OF ELEVATED MICs TO PENICILLINS IN β- HAEMOLYTIC STREPTOCOCCI
HAEMOLYTIC STREPTOCOCCI This specimen was designated as a sample from a skin wound that was to be cultured, identified to species level and susceptibility tested [1-3]. The culture contained a Streptococcus
More informationVariation in erythromycin and clindamycin resistance patterns between New Zealand and Australian group B streptococcus isolates
Australian and New Zealand Journal of Obstetrics and Gynaecology 2011 DOI: 10.1111/j.1479-828X.2011.01302.x Original Article Variation in erythromycin and clindamycin resistance patterns between New Zealand
More informationAntibiotic resistance patterns of group B streptococcal clinical isolates
Infect Dis Obstet Gynecol 24;12:1 8 Antibiotic resistance patterns of group B streptococcal clinical isolates Jose A. Simoes 1,2, Alla A. Aroutcheva 1, Ira Heimler 1 and Sebastian Faro 1,3 1 Department
More informationAntimicrobial resistance in group B streptococcus: the Australian experience
Journal of Medical Microbiology (2011), 60, 230 235 DOI 10.1099/jmm.0.022616-0 Antimicrobial resistance in group B streptococcus: the Australian experience Suzanne M. Garland, 1,2,3,4 Erin Cottrill, 2
More informationPneumococci & streptococci Testing and clinical implications of susceptibility changes
Pneumococci & streptococci Testing and clinical implications of susceptibility changes Pierrette Melin Medical microbiology University Hospital of Liege,, Belgium pm-chu lg - May 2004 1 Key questions What
More informationAntibiotic resistance patterns among group B Streptococcus isolates: implications for antibiotic prophylaxis for early-onset neonatal sepsis
Article Antibiotic resistance patterns among group B Streptococcus isolates: implications for antibiotic prophylaxis for early-onset neonatal sepsis CAPANNA, Federica, et al. Abstract STUDY/PRINCIPLES:
More informationESBL Producers An Increasing Problem: An Overview Of An Underrated Threat
ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic
More informationAnnual Report: Table 1. Antimicrobial Susceptibility Results for 2,488 Isolates of S. pneumoniae Collected Nationally, 2005 MIC (µg/ml)
Streptococcus pneumoniae Annual Report: 5 In 5, a total of, isolates of pneumococci were collected from 59 clinical microbiology laboratories across Canada. Of these, 733 (9.5%) were isolated from blood
More informationCan levaquin treat group b strep
Can levaquin treat group b strep The Borg System is 100 % Can levaquin treat group b strep IBS - Symptoms, Diet and Treatment. IBS, is the common slang term or abbreviation for Irritable Bowel Syndrome
More informationMædica - a Journal of Clinical Medicine
MAEDICA a Journal of Clinical Medicine 2014; 9(2): 157-161 Mædica - a Journal of Clinical Medicine ORIGINAL PAPERS High Incidence of Macrolide and Tetracycline Resistance among Streptococcus Agalactiae
More informationEARS Net Report, Quarter
EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased
More informationAntibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017
Antimicrobial susceptibility of Shigella, 2015 and 2016 Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017
More informationFlorida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More informationNeisseria meningitidis ANTIMICROBIAL RESISTANCE:CURRENT SITUATION IN LATIN AMERICA AND ITS CLINICAL RELEVANCE
Neisseria meningitidis ANTIMICROBIAL RESISTANCE:CURRENT SITUATION IN LATIN AMERICA AND ITS CLINICAL RELEVANCE Dra. Silvia E. González Ayala Head Professor Cátedra Infectología, Facultad Ciencias Médicas,
More informationSerotype distribution and antimicrobial susceptibility of group B streptococci in pregnant women: results from a Swiss tertiary centre
Published 20 March 2014, doi:10.4414/smw.2014.13935 Cite this as: Serotype distribution and antimicrobial susceptibility of group B streptococci in pregnant women: results from a Swiss tertiary centre
More informationORIGINAL ARTICLE. Focus Technologies, Inc., 1 Hilversum, The Netherlands, 2 Herndon, Virginia and 3 Franklin, Tennessee, USA
ORIGINAL ARTICLE In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000 2001 M. E. Jones 1, R. S. Blosser-Middleton
More informationShould we test Clostridium difficile for antimicrobial resistance? by author
Should we test Clostridium difficile for antimicrobial resistance? Paola Mastrantonio Department of Infectious Diseases Istituto Superiore di Sanità, Rome,Italy Clostridium difficile infection (CDI) (first
More informationOBSTETRICS & GYNAECOLOGY. Penicillin G 5 million units IV ; followed by 2.5 million units 4hourly upto delivery
OBSTETRICS & GYNAECOLOGY A.OBSTETRICS Infection/Condition/likely organism Intrapartum Group B Streptococcal (GBS) infection; positive mothers Suggested treatment Preferred Penicillin G 5 million units
More informationKey words: Campylobacter, diarrhea, MIC, drug resistance, erythromycin
Key words: Campylobacter, diarrhea, MIC, drug resistance, erythromycin Table 1 Detection rate of Campylobacter from stool samples taken from sporadic diarrheic patients Table 2 Detection rates of Campylobacter
More informationand Health Sciences, Wayne State University and Detroit Receiving Hospital, Detroit, MI, USA
Journal of Antimicrobial Chemotherapy (2004) 54, Suppl. S1, i7 i15 DOI: 10.1093/jac/dkh313 JAC Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae
More informationPractical Disk Diffusion Test for Detecting Group B Streptococcus with Reduced Penicillin Susceptibility
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 2009, p. 4154 4157 Vol. 47, No. 12 0095-1137/09/$12.00 doi:10.1128/jcm.02063-08 Copyright 2009, American Society for Microbiology. All Rights Reserved. Practical
More informationPrinciples of Antimicrobial Therapy
Principles of Antimicrobial Therapy Doo Ryeon Chung, MD, PhD Professor of Medicine, Division of Infectious Diseases Director, Infection Control Office SUNGKYUNKWAN UNIVERSITY SCHOOL OF MEDICINE CASE 1
More informationEDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update
EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain
More informationResistance Among Streptococcus pneumoniae: Patterns, Mechanisms, Interpreting the Breakpoints
...PRESENTATIONS... Resistance Among Streptococcus pneumoniae: Patterns, Mechanisms, Interpreting the Breakpoints Angela B. Brueggemann, MS; and Gary V. Doern, PhD Presentation Summary Streptococcus pneumoniae
More informationAntimicrobial Resistance Monitoring Program in Food-Producing Animals in Japan
93,0 * Antimicrobial Resistance Monitoring Program in Food-Producing Animals in Japan Tetsuo ASAI* National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, + +/ + Tokura,
More informationOriginal Articles. K A M S W Gunarathne 1, M Akbar 2, K Karunarathne 3, JRS de Silva 4. Sri Lanka Journal of Child Health, 2011; 40(4):
Original Articles Analysis of blood/tracheal culture results to assess common pathogens and pattern of antibiotic resistance at medical intensive care unit, Lady Ridgeway Hospital for Children K A M S
More informationa. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More informationMethicillin-Resistant Staphylococcus aureus
Methicillin-Resistant Staphylococcus aureus By Karla Givens Means of Transmission and Usual Reservoirs Staphylococcus aureus is part of normal flora and can be found on the skin and in the noses of one
More informationAntimicrobial Pharmacodynamics
Antimicrobial Pharmacodynamics November 28, 2007 George P. Allen, Pharm.D. Assistant Professor, Pharmacy Practice OSU College of Pharmacy at OHSU Objectives Become familiar with PD parameters what they
More informationMethicillin-resistant coagulase-negative staphylococci Methicillin-resistant. spa Staphylococcus aureus
126 2005 Methicillin-resistant coagulase-negative staphylococci Methicillin-resistant Staphylococcus aureus 1) 1) 1) 1) 1) 2) 3) 4) 2) 1) MBC 2) 3) 4) 17 3 28 17 8 22 Methicillin-resistant Staphylococcus
More informationGroup b strep and macrodantin
Group b strep and macrodantin The Borg System is 100 % Group b strep and macrodantin 12-10-2017 Group B Streptococcus, also known as Streptococcus agalactiae, was once considered a pathogen of only domestic
More informationSource: Portland State University Population Research Center (
Methicillin Resistant Staphylococcus aureus (MRSA) Surveillance Report 2010 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Health Authority Updated:
More informationBackground and Plan of Analysis
ENTEROCOCCI Background and Plan of Analysis UR-11 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony count, to perform the identification
More informationMultiple drug resistance pattern in Urinary Tract Infection patients in Aligarh
Multiple drug resistance pattern in Urinary Tract Infection patients in Aligarh Author(s): Asad U Khan and Mohd S Zaman Vol. 17, No. 3 (2006-09 - 2006-12) Biomedical Research 2006; 17 (3): 179-181 Asad
More informationNeisseria gonorrhoeae telithromycin in vitro
THE JAPANESE JOURNAL OF ANTIBIOTICS 58 3 37( 97 ) Neisseria gonorrhoeae telithromycin in vitro 4 4 2002 4 2 Neisseria gonorrhoeae 22 telithromycin (TEL) erythromycin (EM), clarithromycin (CAM), penicillin
More informationAbstract. Introduction
ORIGINAL ARTICLE BACTERIOLOGY Molecular characterization and antimicrobial susceptibility profiles in Streptococcus agalactiae colonizing strains: association of erythromycin resistance with subtype III-1
More informationTable 7.5. Drug regimens for the treatment of mastitis. Prevention. Table CDC guidelines for treatment of pelvic inflammatory disease (PID)
Table 7.1. Procedures for collecting clinical specimens for culture of group B Streptococcus (GBS) at 35 37 weeks gestation Swab the lower vagina (vaginal introitus), followed by the rectum (i.e., insert
More informationThe Basics: Using CLSI Antimicrobial Susceptibility Testing Standards
The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More informationSUPPLEMENT ARTICLE. S114 CID 2001:32 (Suppl 2) Diekema et al.
SUPPLEMENT ARTICLE Survey of Infections Due to Staphylococcus Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe,
More informationMedical bacteriology Lecture 8. Streptococcal Diseases
Medical bacteriology Lecture 8 Streptococcal Diseases Streptococcus agalactiae Beat haemolytic Lancifield group B Regularly resides in human vagina, pharynx and large inine Can be transferred to infant
More informationGENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
More informationEarly Onset Neonatal Sepsis (EONS) A Gregory ST6 registrar at RHH
Early Onset Neonatal Sepsis (EONS) A Gregory ST6 registrar at RHH Background Early onset neonatal sepsis (EONS) is a significant cause of mortality and morbidity in newborn babies. Prompt antibiotic treatment
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationOptimization of cluster analysis based on drug resistance profiles of MRSA isolates
Dec. 2015 THE JAPANESE JOURNAL OF ANTIBIOTICS 68 6 325 1 Optimization of cluster analysis based on drug resistance profiles of MRSA isolates HIROYA TANI 1, 2, TAKAHIKO KISHI 2, MINEHIRO GOTOH 2, YUKA YAMAGISHI
More informationJasmine M. Chaitram, 1,2 * Laura A. Jevitt, 1,2 Sara Lary, 1,2 Fred C. Tenover, 1,2 and The WHO Antimicrobial Resistance Group 3,4
JOURNAL OF CLINICAL MICROBIOLOGY, June 2003, p. 2372 2377 Vol. 41, No. 6 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.6.2372 2377.2003 The World Health Organization s External Quality Assurance System Proficiency
More informationDetection of Methicillin Resistant Strains of Staphylococcus aureus Using Phenotypic and Genotypic Methods in a Tertiary Care Hospital
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 7 (2017) pp. 4008-4014 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.607.415
More informationInt.J.Curr.Microbiol.App.Sci (2017) 6(3):
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 3 (2017) pp. 891-895 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.603.104
More informationEUCAST Expert Rules for Staphylococcus spp IF resistant to isoxazolylpenicillins
EUAST Expert Rules for 2018 Organisms Agents tested Agents affected Rule aureus Oxacillin efoxitin (disk diffusion), detection of meca or mec gene or of PBP2a All β-lactams except those specifically licensed
More informationlevofloxacin (LVFX) LVFX LVFX LVFX Key words: Levofloxacin Escherichia coli LVFX levofloxacin (LVFX) Vol. 18 No
2008 221 20 3 14 20 8 1 2001 1 2005 12 5 levofloxacin (LVFX) 5 811 125 27 LVFX (MIC: 4 mg/ml) LVFX LVFX Key words: Levofloxacin Escherichia coli 1) 2 5) 6) ( 203 0036) 2 1 2 TEL: 042 338 5111 2254 FAX:
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
More informationAntimicrobial Susceptibility Testing: Advanced Course
Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to
More informationSuggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
More informationMultidrug-Resistant Salmonella enterica in the Democratic Republic of the Congo (DRC)
Multidrug-Resistant Salmonella enterica in the Democratic Republic of the Congo (DRC) Octavie Lunguya 1, Veerle Lejon 2, Sophie Bertrand 3, Raymond Vanhoof 3, Jan Verhaegen 4, Anthony M. Smith 5, Benedikt
More informationBrief reports. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae
Journal of Antimicrobial Chemotherapy (1997) 40, 105 108 Brief reports JAC Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae Andreas Pikis a *, Jacob A. Donkersloot
More informationInt.J.Curr.Microbiol.App.Sci (2018) 7(8):
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 08 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.708.378
More informationTyphoid fever - priorities for research and development of new treatments
Typhoid fever - priorities for research and development of new treatments Isabela Ribeiro, Manica Balasegaram, Christopher Parry October 2017 Enteric infections Enteric infections vary in symptoms and
More informationDetection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran
Letter to the Editor Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran Mohammad Rahbar, PhD; Massoud Hajia, PhD
More informationORIGINAL ARTICLE. influenzae and Moraxella catarrhalis to antimicrobial agents used to treat respiratory tract infections.
ORIGINAL ARTICLE Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997 98 I. A. Critchley 1, C. Thornsberry
More informationANTHRAX. INHALATION, INTESTINAL and CUTANEOUS ANTHRAX
INHALATION, INTESTINAL and CUTANEOUS ANTHRAX CPMP/4048/01, rev. 3 1/7 General points on treatment Anthrax is an acute infectious disease caused by Bacillus anthracis, that may be infecting man via cutaneous
More informationAntibiotic Susceptibility Pattern of Vibrio cholerae Causing Diarrohea Outbreaks in Bidar, North Karnataka, India
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 957-961 http://www.ijcmas.com Original Research Article Antibiotic Susceptibility Pattern
More informationTwenty Years of the National Antimicrobial Resistance Monitoring System (NARMS) Where Are We And What Is Next?
Twenty Years of the National Antimicrobial Resistance Monitoring System (NARMS) Where Are We And What Is Next? Patrick McDermott, Ph.D. Director, NARMS Food & Drug Administration Center for Veterinary
More informationWhat does multiresistance actually mean? Yohei Doi, MD, PhD University of Pittsburgh
What does multiresistance actually mean? Yohei Doi, MD, PhD University of Pittsburgh Disclosures Merck Research grant Clinical context of multiresistance Resistance to more classes of agents Less options
More informationTHE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS
THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS Stefanie Desmet University Hospitals Leuven Laboratory medicine microbiology stefanie.desmet@uzleuven.be
More informationEUCAST recommended strains for internal quality control
EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC
More informationTel: Fax:
CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.
More informationThe correction pages for the Desk Edition (ISBN ) should be printed on Avery 5168 sheets of labels (3.5 x 5 inch labels/4 per page).
December 1, 2016 Dear Scrub Hill Press Customer: Thank you for your purchase of Obstetrics, Gynecology and Infertility, 7 th Edition (ISBN ISBN-13 978-0982292150 [Pocket] and 978-0982292167 [Desk]). Within
More informationAntimicrobial Susceptibility Patterns of Salmonella Typhi From Kigali,
In the name of God Shiraz E-Medical Journal Vol. 11, No. 3, July 2010 http://semj.sums.ac.ir/vol11/jul2010/88030.htm Antimicrobial Susceptibility Patterns of Salmonella Typhi From Kigali, Rwanda. Ashok
More informationBacterial Resistance of Respiratory Pathogens. John C. Rotschafer, Pharm.D. University of Minnesota
Bacterial Resistance of Respiratory Pathogens John C. Rotschafer, Pharm.D. University of Minnesota Antibiotic Misuse ~150 million courses of antibiotic prescribed by office based prescribers Estimated
More informationRESEARCH ARTICLE ANTIBIOGRAM
RESEARCH ARTICLE ANTIBIOGRAM OF ESCHERICHIA COLI, KLEBSIELLA PNEUMONIAE, AND KLEBSIELLA OXYTOCA FROM INVASIVE DISEASE CASES AT A TERTIARY CARE UNIVERSITY HOSPITAL IN THE CENTRAL REGION OF JAPAN FROM 2008
More informationDefining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate Confirmation Testing
Infect Dis Ther (2015) 4:513 518 DOI 10.1007/s40121-015-0094-6 BRIEF REPORT Defining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate
More information2015 Antimicrobial Susceptibility Report
Gram negative Sepsis Outcome Programme (GNSOP) 2015 Antimicrobial Susceptibility Report Prepared by A/Professor Thomas Gottlieb Concord Hospital Sydney Jan Bell The University of Adelaide Adelaide On behalf
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationKJLM. Evaluation of the MicroScan MICroSTREP Plus Antimicrobial Panel for Testing ß-Hemolytic Streptococci and Viridans Group Streptococci
Korean J Lab Med 2011;31:185-190 Original Article Clinical Microbiology KJLM Evaluation of the MicroScan MICroSTREP Plus Antimicrobial Panel for Testing ß-Hemolytic Streptococci and Viridans Group Streptococci
More informationPneumococcus: Antibiotic Resistance in the Region
Pneumococcus: Antibiotic Resistance in the Region Çiğdem Bal Kayacan Istanbul University Istanbul Faculty of Medicine Department of Microbiology & Clinical Microbiology Drug Resistance in S.pneumoniae
More informationHong-Kai Wang 1, Chun-Yen Huang 1 and Yhu-Chering Huang 1,2*
Wang et al. BMC Infectious Diseases (2017) 17:470 DOI 10.1186/s12879-017-2560-0 RESEARCH ARTICLE Open Access Clinical features and molecular characteristics of childhood communityassociated methicillin-resistant
More informationOverview of C. difficile infections. Kurt B. Stevenson, MD MPH Professor Division of Infectious Diseases
Overview of C. difficile infections Kurt B. Stevenson, MD MPH Professor Division of Infectious Diseases Conflicts of Interest I have no financial conflicts of interest related to this topic and presentation.
More informationA Point Prevalence Survey of Antibiotic Prescriptions and Infection in Sanandaj Hospitals, Prospects for Antibiotic Stewardship
A Point Prevalence Survey of Antibiotic Prescriptions and Infection in Sanandaj Hospitals, Prospects for Antibiotic Stewardship Jafar Soltani* Ann Versporten**, Behzad Mohsenpour*, Herman Goossen**, Soheila
More informationFM - Male, 38YO. MRSA nasal swab (+) Due to positive MRSA nasal swab test, patient will be continued on Vancomycin 1500mg IV q12 for MRSA treatment...
Jillian O Keefe Doctor of Pharmacy Candidate 2016 September 15, 2015 FM - Male, 38YO HPI: Previously healthy male presents to ED febrile (102F) and in moderate distress ~2 weeks after getting a tattoo
More informationEUCAST-and CLSI potency NEO-SENSITABS
EUCASTand CLSI potency NEOSENSITABS Neo Sensitabs Page 1 / 6 Document: 6.2.0 Fastidious organisms EUCAST Interpretation zones and MIC breakpoints according to recommendations by the "Comité de l'antibiogramme
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXVII NUMBER 6 July 2012 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine B. Dowell SM, MLS (ASCP); Sarah K. Parker, MD; James K. Todd, MD Each year the Children s Hospital Colorado
More informationChallenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems
Micro 301 Antimicrobial Drugs 11/7/12 Significance of antimicrobial drugs Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems Definitions Antibiotic Selective
More informationWhat s new in EUCAST methods?
What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests
More informationESCMID Online Lecture Library. by author
Treatment of community-acquired meningitis including difficult to treat organisms like penicillinresistant pneumococci and guidelines (ID perspective) Stefan Zimmerli, MD Institute for Infectious Diseases
More informationAntibiotic Updates: Part II
Antibiotic Updates: Part II Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures
More informationPalpasa Kansakar, Geeta Shakya, Nisha Rijal, Basudha Shrestha
In-vitro resistance of Salmonella Typhi and Paratyphi A raises concern on the use of older fluroquinolones in the empiric treatment of enteric fever in Nepal Palpasa Kansakar, Geeta Shakya, Nisha Rijal,
More informationTitle: N-Acetylcysteine (NAC) Mediated Modulation of Bacterial Antibiotic
AAC Accepts, published online ahead of print on June 00 Antimicrob. Agents Chemother. doi:0./aac.0070-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationAntibiotic sensitivity of bacteria on the oral mucosa. after hematopoietic cell transplantation
Antibiotic sensitivity of bacteria on the oral mucosa after hematopoietic cell transplantation Yoshihiko Soga 1, Yoshinobu Maeda 2, Mitsune Tanimoto 2, Takayuki Ebinuma 3, Hiroshi Maeda 3, Shogo Takashiba
More informationNorth West Neonatal Operational Delivery Network Working together to provide the highest standard of care for babies and families
Document Title and Reference : Guideline for the management of multi-drug resistant organisms (MDRO) Main Author (s) Simon Power Ratified by: GM NSG Date Ratified: February 2012 Review Date: March 2017
More informationVolume-7, Issue-2, April-June-2016 Coden IJABFP-CAS-USA Received: 5 th Mar 2016 Revised: 11 th April 2016 Accepted: 13 th April 2016 Research article
Volume-7, Issue-2, April-June-2016 Coden IJABFP-CAS-USA Copyrights@2016 Received: 5 th Mar 2016 Revised: 11 th April 2016 Accepted: 13 th April 2016 Research article A STUDY ON ANTIBIOTIC SUSCEPTIBILITY
More informationAntimicrobial Cycling. Donald E Low University of Toronto
Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and
More informationAppropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases
Appropriate Management of Common Pediatric Infections Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases It s all about the microorganism The common pathogens Viruses
More informationFailure of Cloxacillin in a Patient with BORSA Endocarditis ACCEPTED
JCM Accepts, published online ahead of print on 30 December 2008 J. Clin. Microbiol. doi:10.1128/jcm.00571-08 Copyright 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All
More informationStreptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance
Streptococcus pneumoniae Oxacillin µg as screen for beta-lactam resistance Version 6. June Streptococcus pneumoniae and zone diameter correlates The following histograms present inhibition zone diameter
More informationThis is an author version of the contribution published on: Corcione S,Motta I,Fossati L,Campanile F,Stefani S,Cavallo R,Di Perri G,Ranieri VM,De Rosa FG Molecular epidemiology of methicillin-resistant
More informationCompliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
More informationMolecular epidemiology of community-acquired methicillin-resistant Staphylococcus aureus bacteremia in a teaching hospital
Epidemiology J Microbiol Immunol of MRSA Infect. bacteremia 2007;40:310-316 Molecular epidemiology of community-acquired methicillin-resistant Staphylococcus aureus bacteremia in a teaching hospital Chih-Yu
More informationDrd. OBADĂ MIHAI DORU. PhD THESIS ABSTRACT
UNIVERSITY OF AGRICULTURAL SCIENCES AND VETERINARY MEDICINE ION IONESCU DE LA BRAD IAŞI FACULTY OF VETERINARY MEDICINE SPECIALIZATION MICROBIOLOGY- IMUNOLOGY Drd. OBADĂ MIHAI DORU PhD THESIS ABSTRACT RESEARCHES
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007
More information